Search

Displaying results 5891 - 5900 of 7017 in total
  1. Drug

    Bufezolac

    go.drugbank.com/drugs/DB21081
    Experimental

    Bufezolac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Bufezolac is a anti-inflammatory agent, ibufenac derivative. … Bufezolac has a monoisotopic molecular weight of 334.17 Da.

  2. Drug

    Mofezolac

    go.drugbank.com/drugs/DB21153
    Experimental

    Mofezolac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Mofezolac is a anti-inflammatory agent, ibufenac derivative. … Mofezolac has a monoisotopic molecular weight of 339.11 Da.

  3. Drug

    Trifezolac

    go.drugbank.com/drugs/DB21380
    Experimental

    Trifezolac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Trifezolac is a anti-inflammatory agent, ibufenac derivative. … Trifezolac has a monoisotopic molecular weight of 354.14 Da.

  4. Drug

    Ipatasertib

    go.drugbank.com/drugs/DB11743
    Investigational

    Ipatasertib has been used in trials studying the treatment of Cancer, Neoplasms, Solid Cancers, Breast Cancer, and Gastric Cancer, among others.

    Categories: Proto-Oncogene Proteins c-akt, antagonists & inhibitors
  5. Drug

    ICX-RHY

    go.drugbank.com/drugs/DB05716
    Experimental

    ICX-RHY is an investigational therapy comprised of cultured allogeneic fibroblasts.

  6. Drug

    Picoplatin

    go.drugbank.com/drugs/DB04874
    Investigational

    Picoplatin is a cytotoxic platinum compound in clinical development for the treatment of patients with solid tumors. … It causes apoptosis (cell death) by binding to DNA and interfering with DNA replication and transcription.

  7. Drug

    Clinafloxacin

    go.drugbank.com/drugs/DB14025
    Experimental

    Clinafloxacin is a fluoroquinolone antibacterial currently under research. It has been proven to present good antibiotic properties.

  8. Drug

    Zinpentraxin alfa

    go.drugbank.com/drugs/DB14852
    Investigational

    Zinpentraxin alfa is a recombinant form of PTX-2, a naturally circulating human protein. … It is under investigation in clinical trial NCT01981850 (A Phase 2 Study Of PRM-151 In Subjects With Myelofibrosis).

  9. Drug

    Ligufalimab

    go.drugbank.com/drugs/DB17542
    Investigational

    It is under investigation in clinical trial NCT04900350 (A Trial of AK117 (Anti-cd47) in Patients With Myelodysplastic Syndrome). … Ligufalimab is a humanized immunoglobulin G4 (IgG4) monoclonal antibody targeting leukocyte surface antigen CD47.

  10. Drug

    Zirconium panitumumab Zr-89

    go.drugbank.com/drugs/DB19228
    Investigational

    Zirconium panitumumab Zr-89 is under investigation in clinical trial NCT05423197 (Study Evaluating Zr-panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in Head and Neck Squamous